Squarepoint
LLY icon

Squarepoint’s Eli Lilly LLY Stock Holding History

Squarepoint’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55.4M Buy
46,200
+13,300
+40% +$13.6M 0.06% 304
2026
Q1 		$30.3M Sell
32,900
-40,500
-55% -$41.1M 0.04% 508
2025
Q4 		$78.9M Sell
73,400
-2,400
-3% -$2.29M 0.08% 263
2025
Q3 		$57.8M Sell
75,800
-56,600
-43% -$42.1M 0.06% 368
2025
Q2 		$103M Sell
132,400
-11,400
-8% -$8.86M 0.11% 200
2025
Q1 		$119M Sell
143,800
-91,500
-39% -$76.1M 0.14% 129
2024
Q4 		$182M Buy
235,300
+161,100
+217% +$133M 0.18% 83
2024
Q3 		$65.7M Buy
74,200
+47,300
+176% +$42.5M 0.1% 180
2024
Q2 		$24.4M Sell
26,900
-69,400
-72% -$55.5M 0.04% 493
2024
Q1 		$74.9M Buy
96,300
+6,300
+7% +$4.48M 0.13% 150
2023
Q4 		$52.5M Sell
90,000
-41,400
-32% -$24.2M 0.1% 213
2023
Q3 		$70.6M Buy
131,400
+94,900
+260% +$48.9M 0.17% 102
2023
Q2 		$17.1M Buy
36,500
+35,300
+2,942% +$14.8M 0.05% 445
2023
Q1 		$412K Sell
1,200
-5,600
-82% -$1.89M ﹤0.01% 2405
2022
Q4 		$2.49M Sell
6,800
-101,600
-94% -$36M 0.01% 1239
2022
Q3 		$35.1M Buy
108,400
+91,800
+553% +$29.1M 0.18% 109
2022
Q2 		$5.38M Buy
16,600
+7,100
+75% +$2.13M 0.03% 641
2022
Q1 		$2.72M Sell
9,500
-41,600
-81% -$10.7M 0.01% 973
2021
Q4 		$14.1M Sell
51,100
-600
-1% -$152K 0.04% 411
2021
Q3 		$11.9M Buy
51,700
+500
+1% +$123K 0.03% 442
2021
Q2 		$11.8M Buy
51,200
+47,200
+1,180% +$9.48M 0.04% 406
2021
Q1 		$747K Buy
4,000
+2,700
+208% +$528K ﹤0.01% 1735
2020
Q4 		$219K Sell
1,300
-500
-28% -$74.7K ﹤0.01% 2447
2020
Q3 		$266K Buy
1,800
+500
+38% +$77.4K ﹤0.01% 1892
2020
Q2 		$213K Buy
+1,300
New +$200K ﹤0.01% 1795
2020
Q1 		– Sell
-4,100
Closed -$539K – 2225
2019
Q4 		$539K Buy
4,100
+2,100
+105% +$243K ﹤0.01% 1730
2019
Q3 		$224K Buy
+2,000
New +$223K ﹤0.01% 2035

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Squarepoint's LLY Position: Q2 2026 in Review

Squarepoint reduced its Eli Lilly (LLY) stake by 15% in Q2 2026, selling an estimated $45.6M and leaving 245,569 shares worth $295M. The position accounts for 0.33% of the portfolio, ranked #44.

Squarepoint first reported a position in LLY in Q1 2015 and has held it in 34 quarters since. The position peaked at $346M in Q3 2025. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Squarepoint held 245,569 shares of Eli Lilly worth $295M as of Q2 2026.
  • Squarepoint sold 44,612 Eli Lilly shares in Q2 2026, an estimated $45.6M.
  • Eli Lilly made up 0.33% of Squarepoint's portfolio in Q2 2026, its #44 holding.
  • Squarepoint first reported a position in Eli Lilly in Q1 2015 and has held it in 34 quarters since.
  • Squarepoint's Eli Lilly position peaked at $346M in Q3 2025.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.